Preparation and Characterization of M. × Piperita L. Oil Based Gel Formulation

The essential oil of M. × piperita L. was formulated into a topical gel. The prepared gel was characterized for its pH, viscosity, spreadiblity, consistency and extrudiblity, while its stability was evaluated under different temperature conditions. The prepared M. × piperita oil gel was clear and transparent. The pH value of developed gel was 6.6, while its viscosity was 1200 cP. Spreadability and consistency of the M. × piperita oil gel was 10.7 and 7 mm, respectively. The prepared gel showed good extrudiblity. During the stability studies, no significant change in pH and viscosity as a function of time for gel was observed, indicating stability of prepared formulation. The gel developed in this study is expected to forward the usage of M. × piperita essential towards commercial application.

[1] Baris O, G├╝ll├╝ce M, Shahin F, ├ûzer H, Kilic H, ├ûzkan H, Sökmen M,
Özber T (2006). Biological activities of the essential oil and methanol
extract of Achillea biebersteinii (Asteraceae) Turk J Biol 30: 65-73.
[2] Kumar P, Mishra S, Malik A, Satya S (2011). Repellent, larvicidal
and pupicidal properties of essential oils and their formulations against
the housefly, Musca domestica. Med Vet Entomol
[3] Werka JS, Boehme AK, Setzer WN (2007). Biological activities of
essential oils from Monteverde, Costa Rica. Nat Prod Commun 2: 1215-
[4] Ormancey X, Sisalli S, Coutiere P (2001). Formulation of essential oils
in functional perfumery. Parfums Cosmetiques Actualites 157: 30-40.
[5] Bagwe RP, Kanicky JR, Palla BJ, Pantajali PK, Shah DO (2001).
Improved drug delivery using microemulsions: rationale, recent
progress and new horizons. Crit Rev Ther Drug 18: 77-140.
[6] Manou I, Bouillard L, Devleschouwer MJ, Barel AG (1998). Evaluation
of the preservative properties of Thymus vulgaris essential oil in
topically applied formulations under a challenge test. J Appl Microbiol
84: 368 376.
[7] Orafidiya LO, Oyedele AO, Shittu AO, Elujoba AA(2001). The
formulation of an effective topical antibacterial product containing
Ocimum gratissimum leaf essential oil. Int J Pharm 224: 177-83.
[8] Oyedele, AO, Gbolade AA, Sosan MB, Adewoyin FB, Soyelu OL,
Orafidiya OO (2002). Formulation of an effective mosquitorepellent
topical product from lemongrass oil. Phytomedicine 9: 259-262.
[9] Quinones D, Ghaly ES (2008). Formulation and characterization of
nystatin gel. P R Health Sci J 27: 61-67.
[10] Kumar S, Himmelsten K (1995) Modification of in situ gelling behavior
of carbopol solution by Hydroxypropyl methyl cellulose. J Pharm Sci
[11] Rama rao P, Diwan PV (1998) Formulation and In vivo Evaluation of
Polymeric Film Diktiazim Hydrochloride and Indomethacin for
Transdermal Administration. Drug Dev. Ind Pharm 24:327-338.
[12] Lee B, Choi W, Lee S, Park B (2001). Fumigant toxicity of essential oils
and their constituent compounds towards the rice weevil, S. oryzae (L.).
Crop Prot 20: 317-320.
[13] Bakkali F, Averbeck S, Averbeck D, Idaomar M (2008). Biological
effects of essential oils. Rev Food Chem Toxicol 46: 446-475.
[14] Kumar P, Mishra S, Malik A, Satya S (2012). Efficacy of Mentha
×piperita and Mentha citrata essential oils against housefly, Musca
domestica L. Ind Crop Prod 39 (2012) 106- 112
[15] Shivhare UD, Jain KB, mathur V B, Bhusari K P, Roy A (2009).
Formulation development and evaluation of diclofenac sodium gel using
water soluble polyacrylamide polymer. Dig J Nanomater Bios 4: 285-
[16] William L (2000) Remington: The Science and Practice of Pharmacy.
20th edition. Mack Publishing Company. Easton, PA.
[17] Bhanu PV, Shanmugam V, Lakshmi P K (2011) Development And
Optimization Of Novel Diclofenac Emulgel for Topical Drug Delivery .
Internat J Compre Pharmacy 9 (10): 1-4.
[18] ICH Harmonized Tripartite Guidelines (2003) Stability Testing of New
Drug Substances and Products. ICH Committee 8.
[19] Kumar R, Patil MB, Patil SR, Paschapur MS (2009) Evaluation of
Anacardium occidentale gum as gelling agent in Aceclofenac Gel. Int J
ChemTech Res Coden (USA): Ijprif. 1 (3): 695-704.